Search - tctmd.com

Displaying 21 - 40 of 169

Sort: Relevancy | Date

Presentation TCT 2023

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

Presenter: Fabio Enrique Posas

October 26, 2023

Presentation TCT 2023

TCT 386: Sapien 3 in Degenerated Calcified Evolut: Assessing Hydrodynamic Function and Leaflet Kinematics After Redo-TAVR

Presenter: Janarthanan Sathananthan

October 25, 2023

Presentation TCT 2023

TCT 954: High Risk Left Main Stenting through EVOLUT Valve with Impella Support from Axillary Access

Presenter: Sze Jia Ng

October 25, 2023

Presentation TCT 2023

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

Presenter: Guilherme Attizzani

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

Presentation TCT 2023

TCT 32: Predicting Commissural Alignment for the Evolut Valve Using 3D Modeling and Printing

Presenter: Osama Elkhateeb

October 25, 2023

Presentation TCT 2023

TCT 663: The Evolution of Artificial Intelligence (AI) Capabilities in the Peripheral Endovascular Field

Presenter: Anthony Pham

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

TCT 383: Feasibility of TAV-in-TAV in Evolut valves using in-vivo CT sizing and its impact on coronary obstruction and patient prosthesis mismatch

Presenter: Atsushi Okada

October 24, 2023

Presentation TCT 2023

TCT 133: Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

Presenter: Kendra Grubb

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

The Emerging Era of Decentralized Care: Insights From a Novel Model of Remote Clinical Care Management

Presenter: Lou Silverman

October 23, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

Presentation TCT 2022

TCT 603: Evolution of Alternative Access Approaches in a High-Volume TAVR Center

Presenter: Rohit Masih

September 19, 2022

Presentation TCT 2022

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Presenter: Reda Ibrahim

September 18, 2022

Presentation TCT 2022

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Presenter: Scott Lim

September 18, 2022

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Advances in Transcatheter Therapy for SMR: Imaging Evolution, Ventricular Remodeling, and Emerging Devices

Presenter: Azeem Latib

September 17, 2022

Advertisement

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

TCT 386: Sapien 3 in Degenerated Calcified Evolut: Assessing Hydrodynamic Function and Leaflet Kinematics After Redo-TAVR

TCT 954: High Risk Left Main Stenting through EVOLUT Valve with Impella Support from Axillary Access

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

TCT 32: Predicting Commissural Alignment for the Evolut Valve Using 3D Modeling and Printing

TCT 663: The Evolution of Artificial Intelligence (AI) Capabilities in the Peripheral Endovascular Field

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

TCT 383: Feasibility of TAV-in-TAV in Evolut valves using in-vivo CT sizing and its impact on coronary obstruction and patient prosthesis mismatch

TCT 133: Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

Four-Year Outcomes From the EVOLUT Low Risk Trial

The Emerging Era of Decentralized Care: Insights From a Novel Model of Remote Clinical Care Management

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

TCT 603: Evolution of Alternative Access Approaches in a High-Volume TAVR Center

Patient Selection for PFO Closure in 2022: An Evolutionary Process

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

FLASH: More Data to Support Mechanical Thrombectomy in PE

Advances in Transcatheter Therapy for SMR: Imaging Evolution, Ventricular Remodeling, and Emerging Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content